Kobayashi Pharmaceutical Co., Ltd. (TYO: 4967)

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 41.32B JPY in the quarter ending September 30, 2024, a decrease of -9.16%. This brings the company's revenue in the last twelve months to 168.80B, down -1.34% year-over-year. In the year 2023, Kobayashi Pharmaceutical had annual revenue of 173.46B with 4.33% growth.

• Revenue (ttm): 168.80B
• Revenue Growth: -1.34%
• P/S Ratio: 2.63
• Revenue / Employee: 47.76M
• Employees: 3,534
• Market Cap: 443.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	173.46B	7.20B	4.33%
Dec 31, 2022	166.26B	11.01B	7.09%
Dec 31, 2021	155.25B	4.74B	3.15%
Dec 31, 2020	150.51B	-17.54B	-10.44%
Dec 31, 2019	168.05B	573.00M	0.34%